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Abstract. Protein factors play a crucial role in establishing gene-specific and cell-specific 
regulation of the process of transcription. These include general transcription factors which 
recognize TATA and CCAAT boxes and which form components of the RNA polymerase 
II system. Specific transcription factors interact with characteristic promoter elements of 
individual genes. Some of the examples are SP1, glucocorticoid receptor, GCN4, GAL4 
and many others. Transcription factors have a DNA binding domain demarcated from the 
transcription activation domain. Some factors may have an additional ligand (small 
molecule) binding domain. Typical structural features such as helix-turn-helix motif, zinc 
finger and leucine zipper have been recognized in the DNA binding domain of the 
transcription factors. The acidic domain of the protein factors is involved in the 
transcription activation process. It appears that activation is the result of the combined 
action of several regulatory proteins binding at different regions of the promoter. 
Interaction between proteins bound to DNA but seperated by long stretches of nucleotides 
is facilitated by DNA bending. Functional specificity as well as diversity are feasible with a 
limited number of transcription factors through alterations in the architecture of 
interaction  between  a  group  of  proteins  bound  to promoter elements. 
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Introduction 
 
In eukaryotes, multiple sequence-specific DNA-protein interactions occurring at 
distinct upstream regions regulate the initiation of transcription. Promoters of 
eukaryotic protein coding genes are characterized by the presence of a TATA box 
(TATA A )located 20–30 basepairs (bp) upstream of transcription initiation site. 
The TATA box present in eukaryotes is analogous to the Pribnow box (TATAAT) 
present in bacterial genes. It specifies the position where RNA synthesis is to begin 
and also determines which of the two DNA strands is to be transcribed (Corden et 
al., 1980). The sequence GCTCAATCT known as the CCAAT box is usually present
70–90 nucleotides upstream of the transcription initiation site and a family of
transcription factors, referred to as the CCAAT binding proteins interact with these 
sequence elements (Chodosh et al, 1988). In addition, several regulatory sequences 
such as enhancers, silencers etc., located upstream of the TATA box and CCAAT 
box govern the efficiency of transcription. Enhancers have also been detected 
downstream of transcription initiation site. Purified RNA polymerase II initiates 
transcription randomly or at structures such as nicks, free ends etc., and thus 
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behaves like the bacterial core polymerase. However, in the presence of crude 
nuclear extracts, RNA polymerase II transcription comes under strict promoter 
control (Lewis and Burgess, 1980). These crude nuclear extracts contain several 
auxillarly proteins referred to as transcription factors which interact with specific 
regulatory sequences and bring about accurate and efficient transcription. Several of 
these factors have been purified and biochemically characterized and are shown to 
promote specific and accurate initiation of transcription in vitro. A large number of 
transcription factors acting on a variety of eukaryotic promoters in a complex 
interactive manner have been identified. Some typical examples of transcription 
factors are listed in table 1. In this brief review, the regulation of RNA polymerase 
II  transcription  is  discussed  with  selected  examples. 
 
General transcription factors 
 
Factors that bind to common promoter elements such as TFIIA, TFIIB, TFIID, 
TFIIE and TFIIF isolated from HeLa cell extracts bind to TATA box and promote 
transcription in cell-free systems. Sopa et al. (1986) purified several RNA polymerase 
II associated proteins (RAPs) utilizing RNA polymerase II affinity columns. These 
include RAP30, RAP38 and RAP74. RAP30 is a functional component of TFIIF, 
whereas, RAP38 is required for transcription elongation. SP2 also purified from 
HeLa cell extracts, is yet another general transcription factor, known to promote 
transcription from several eukaryotic promoters such as SV40, adenovirus 2 major 
late promoter, human β-globin and avian sarcoma virus (Dynan and Tjian, 1983), 
Two factors, A and Β are required for accurate initiation of transcription in. 
Drosophila cell extracts. Factor Β binds near the TATA box and is compared to 
TFIIC and TFIID found in HeLa cell extracts (Parker and Topol, 1984a). A 
protein factor binding specifically to the TATA box of heat shock genes has been 
identified in Drosophila. It is postulated that all the TATA binding functions are 
governed by a family of proteins, each recognizing a unique sequence surrounding 
the  TATA  box  core  sequence  (Wu,  1985). 
Several factors binding to the CCAAT box of various eukaryotic promoters have 
been identified. These include (i) CP 1, binding to the CCAAT sequence of human α- 
globin promoter and adenovirus major late promoter, (ii) CP2, binding to the 
CCAAT element of γ-fibrinogen promoter and (iii) the nuclear factor I(NFI), 
regulating transcription and replication in adenovirus. CP 1, CP2 and NF I appear 
to be distinct proteins in that each binds to its own recognition site with an affinity
that is several orders of magnitude higher than that with which it binds to the 
recognition sequences of the other two proteins. These factors, categorized as 
CCAAT binding proteins, thus show specificity, at the same time perform diverse 
functions such as regulation of transcription and replication, perhaps through micro 
heterogeneity  in  their  structure  and  heteromer  formation  (Chodosh  et  al,  1988). 
 
Specific transcription factors 
 
A variety of gene-specific and tissue-specific transcription factors have been 
identified and only a few examples will be discussed here. The factor SP1 purified 
from HeLa cell extracts binds specifically the sequence   and this 
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Table 1. (Contd.) 
  *For a complete list of eukaryotic transcription factors and their recognition sequences 
refer  Wingender  (1988). 
 
 
sequence is present in several eukaryotic promoters (Briggs et al., 1986). Kadonaga 
et al. (1987) have shown that amino acids present in the C-terminal region of SP1 
factor is responsible for the DNA binding. SP 1 is not a tissue-specific factor since it 
was  detected  in  the  nuclear  extracts  of  several  tissues. 
A heat shock transcription factor (HSTF) binding to the heat shock responsive 
element (CTnnGAAnnTCnAG) has been identified in Drosophila, yeast and man 
(Widerrecht et al, 1987). HSTF has been purified and shown to stimulate 
transcription from hsp70 promoter in vitro (Parker and Topol, 1984b). 
One of the well characterized transcription factors in higher eukaryotes is the 
glucocorticoid receptor that binds the glucocorticoid regulatory element (GRE) 
bearing the consensus sequence TGT/CCT. GRE is present in the promoters of 
several eukaryotic genes such as uteroglobin, metallothionin, chicken lysozyme 
etc. (Renkawitz et al., 1984a). The binding sites for the progesterone receptor (Jost 
et al., 1984) and estrogen receptor (Renkawitz et al, 1984b) are also known. In fact, 
it was reported that a 15bp sequence mediates both glucocorticoid and progeste 
rone induction of transcription suggesting that these proteins may bind similar 
sequences (Strahle et al., 1987). The mechanism of activation of transcription by 
steroid hormone receptors is still not known. According to one view, the receptor is 
present in the cytosol in complex with a heat shock protein (hsp90) and steroid 
binding releases the receptor and allows its nuclear localization (Sanchez et al, 
1985). Becker et al. (1986) argue that the ligand-free receptor itself can bind to target 
DNA sequences and steroid binding induces a conformational change in the 
receptor that alters its contacts with DNA. Recently, Godowski et al. (1988), have 
reported that transcriptional enhancement by glucocorticoid receptor requires 
hormone binding and the unliganded hormone binding region can inhibit all 
receptor activities other than hormone binding itself. They suggest that the 
unliganded hormone binding domain forms a complex with hsp90 and the formation 
of such a complex inhibits receptor function. Hormone binding derepresses receptor 
activity by altering the conformation of hormone binding domain and disrupting the 
receptor-hsp90 interactions. 
A plethora of factors regulating RNA polymerase II transcription have been 
identified in yeast. These include GAL4, GCN4, HAP1, HAP2, MATα2 and ADR1 
gene products. The GAL4 protein regulates the transcription of GAL 1 gene by 
binding to an upstream activation sequence (UAS) called UASG. The first 74 N- 
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terminal amino acids of GAL4 protein are involved in DNA binding, while amino 
acid residues 148–196 and 768–881 are involved in transcription activation (Ma and 
Ptashne,  1987a). 
The GCN4 protein promotes transcription of several co-regulated genes in 
response to amino acid starvation (general amino acid control). GCN4 protein 
binds a 9bp palindrome, ATGAC/GTCAT, which is also recognized by the 
mammalian transcription factor AP1 as well as the jun oncoprotein (Rausher et al, 
1988). The DNA binding domain of GCN4 protein lies in the 60 C-terminal amino 
acid residues. The C-terminus also has a 19 amino acid long acidic domain that is 
implicated  in  transcription  activation  function  (Hope  and  Struhl,  1986). 
The iso-1-cytochrome C gene(CYCl) of yeast contains two UASs known as 
UAS1 and UAS2 which interact with proteins coded by HAP1, HAP2 and HAP3 
loci (Guarente and Hoar, 1984). HAP 1 product binds at UAS 1, whereas UAS2 is 
activated by the combined action of HAP2 and HAP3 proteins. HAP1 protein also 
binds the UAS of CYC7 gene with equal affinity. However, there is no sequence 
homology between UASl of CYC1 gene and the UAS of CYC7 gene (Pfeifer et al, 
1987). Thus HAPl protein is a rare example of a transcription factor binding two 
unrelated sequences. Other transcription factors identified in yeast include the 
MATα2 protein (Johnson and Herskowitz, 1985) and the ADR1 gene product 
(Hartshore et al., 1986). The latter is required for the transcriptional activation of 
alcohol  dehydrogenase  gene. 
Several transcriptional factors expressed in selective tissues have been identified; 
A liver specific transcription factor referred to as NFI-L, binding to a sequence 
similar to that recognized by NFI (TGGCA) has recently been identified (Paonessa 
et al., 1988). Similarly, Courtois et al (1988), purified a 88 kDa protein binding to 
the α1 -antitrypsin gene promoter and this is identified as hepatocyte specific nuclear 
factor (HNF1). A pitutary-specific factor called Pit-1, regulating the transcription of 
prolactin and growth hormone genes in the lactotrophs and somatotrophs of 
pitutary gland has been reported (Nelson et al, 1988). An erythroid-specific factor 
called ERYF-1, binding to the sequence AGATAA of chicken globin genes was 
shown to play a prominent role in the initial establishment of erythroid cell lineage 
(Evans et al, 1988). Other tissue-specific factors include the octamer binding protein 
of immunoglobulin genes expressed in Β cells and that expressed in sea urchin testis 
(Barberis et al., 1987). Several factors claimed to be tissue-specific, were later found 
to induce transcription in other tissues as well For example, the factor NF- κß, 
binding to Igκ -enhancer and expressed only in κ-producing cells was later shown to 
be  induced  by  phorbol  esters  in  HeLa  cells  as  well  (Sen  and  Baltimore,  1986). 
 
Structure of the DNA binding domain of transcription activators 
 
Despite several unique characteristics of their own, transcription factors share some 
common structural features so that certain generalizations can be made. Majority of 
these factors are sequence-specific DNA binding proteins and contain two major 
functional domains, namely, the DNA binding domain and the transcription 
activation domain. Proteins like steroid hormone receptors possess an additional 
domain for ligand binding. In addition, several of these proteins interact with other 
proteins of the transcription machinery through their carboxy terminii. Many of the 
transcription factors show considerable homology in their DNA binding domains 
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and studies so far have led to the identification of 3 major DNA binding motifs, 
namely,  the  helix-turn-helix  motif,  the  zinc finger  motif  and  the  leucine  zipper. 
 
Helix-turn-helix motif 
 
This motif was first identified in the DNA binding domain of prokaryotic 
regulatory proteins such as λ-repressor, cro protein, Escherichia coli Gal repressor, 
Lac repressor and Trp repressor (Pabo and Sauer, 1984). A similar motif was later 
identified in the yeast ΜΑΤα2 protein and certain homeotic products of Drosophila 
(Sheperd et al., 1984). This motif is characterized by the presence of two a-helices, 
one of which called the helix3, lies within the major groove of DNA while the other 
lies across. Helix3 plays a major role in DNA recognition and mutation of amino 
acids in helix3 leads to weak promoter recognition. Amino acids that form the 
hinge region between the two α-helices are highly conserved among all these 
proteins. The helix-turn-helix motif lies in the amino terminus while the carboxy 
terminal amino acids provide sites for the dimerization of two monomers such that 
the axis of 2-fold symmetry of the dimer is coincident with that of DNA. These 
proteins dock with operators in the B-form. Hydrogen bonds and van der Waals 
forces are involved in the interactions between the amino acid side chains and edges 
of bases in the major groove of DNA. These, together with the backbone and 
electrostatic interactions stabilize DNA-protein complexes (Ptashne et al., 1982) 
(figure 1). 
 
 
Figure 1. (A) The helix-turn-helix motif of λ-repressor. Amino acids 33(GLN), 37(ALA), 
41(GLY) and 47(VAL) are highly conserved among all the prokaryotic repressor proteins. 
In addition, glycine at position 41 is usually flanked by hydrophobic amino acids. The 
angle between the helix2 and helix3 is controlled by the contact between the side chains of 
alanine at position 37 and valine at position 47. (B) Interaction of λ-repressor with the 
operator DNA. 
 
Zinc finger motif 
 
The zinc finger motif was first identified in the DNA binding domain of transcription 
factor IIIA(TFIIIA) which activates transcription from promoters recognized by 
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RNA polymerase III. Similar motifs were later discovered in the ADR1 gene 
product of yeast, the gag gene product of retroviruses, ElA gene product of 
adenovirus, large Τ antigen of papova viruses, the SP1 factor and the product of 
Drosophila developmental regulatory loci like kruppel and serendipity (Berg, 1986; 
Rosenber, 1986). The sex determining region of human Υ chromosome was shown 
to  encode  a  finger  protein  (Page  et  al.,  1987). 
TFIIIA is a 40 kDa polypeptide with a 30 kDa aminoterminal domain retaining 
DNA binding activity and a 10 kDa carboxy terminal domain involved in 
transcription activation (Smith, 1984). Zinc (7-11 atoms) are complexed with each 
TFIIIA molecule. The DNA binding domain of TFIIIA consists of 9 homologous 
subunits termed zinc fingers. Each zinc finger is composed of 30 amino acids and 
contain the sequence of the form Cys-X2-5-Cys-X12-His-X2.3-His, where X may be 
any amino acid. Each of the 30 amino acid domains of TFIIIA forms a loop or 
finger of 12 amino acids, the base of which is formed by Zn2+ bound by Cys and 
His residues (figure 2). The amino acids in the loop bind DNA with each finger 
interacting with one half turn of the helix (Rhodes and Klug, 1986). Analysis of the 
crystal structure of a double stranded nonadeoxynucleotide that corresponds to the 
tightest binding part of the sequence recognized by TFIIIA revealed that it has an 
Α-type rather than a B-type conformation (McCall et αl., 1986). TFIIIA molecule 
binds to the internal control region of the 5S rRNA gene between the nucleotides 
+40 and +90 and this interaction is stabilized by the sequential binding of two 
other protein factors called Β and C. Each of the 9 finger domains of TFIIIA 
interacts with about half a DNA period and thus the 9 domains cover the entire 
internal control region. An advantage of the multiple fingers is that the stable 
transcriptional complex, once formed, can sustain several rounds of transcription, 
during which process the factor remains bound to the gene. As the RNA 
polymerase III passes through the gene, the multifingered protein releases the 
fingers bound ahead of the progressing polymerase but remains bound to the DNA 
by  its  remaining  fingers  (Miller  et al,  1985). 
When genomic libraries of different animals were screened with a probe coding 
 
 
Figure 2. The zinc finger motif of Xenopus TFIIIA. Only two of the 9 repetitive motifs 
are shown. (●), Most probable DNA binding side chains. F, phenyl alanine; L, leucine; C,
cysteine;  Η,  histidine;  D, aspartic  acid; Y, tyrosine. 
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for the finger domain, several copies of homologous DNA sequences were detected 
suggesting that several finger proteins exist in eukaryotes and these are well 
conserved  during  evolution  (Schutz  et  al.,  1986). 
 
Leucine zipper 
 
Landschulz et al. (1988) identified a new motif termed leucine zipper in the CCAAT 
box and enhancer binding protein (C/EBP) of rat liver nuclei. A computer search 
revealed that a similar motif is present in several other DNA binding proteins such 
as mouse c-myc, human N-myc, human L-myc, v-jun, v-fos and GCN4. The region 
of homology is characterized by a periodic repetition of leucine residues at every 
seventh position over a distance covering 8 helical turns. The leucine repeats in 
these proteins can form an α-helix with the leucine side chains projecting out from 
the helix at regular intervals (figure 3A). It was proposed that the leucine side chains 
from one protein molecule interdigitate with those on the other forming a zipper 
that holds the two molecules together and this dimerization facilitates appropriate 
positioning of amino acid side chains of these proteins into the grooves of the 
double helical DNA (figure 3B). Thus the leucine zipper is not directly involved in 
DNA binding but aligns the interacting protein molecules alongside the DNA such 
that atomic interactions can take place between the amino acid side chains and the 
bp of DNA. 
 
 
Figure 3. Leucine zipper of the C/EBP. (A) Location of the leucine repeat within the 
C/EBP polypeptide. The DNA binding domain lies beyond the leucine zipper domain 
towards the aminoterminus of the protein (striped region). (B) A hypothetical model of 
the C/EBP dimer formed by the interdigitation of the leucine zipper domains in an 
antiparallel conformation. 
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Mechanism of transcription activation 
 
Role of acidic amino acids in transcription activation 
 
Analysis of the transcription activation domain of certain transcription factors 
revealed that a group of acidic amino acids conferring a net negative charge may 
play an important role in activation of transcription. It was observed that the 
transactivation domain of GAL4 protein is composed of several acidic amino acids 
and mutational analysis confirmed that the negative charge is essential for transcrip- 
tion activation function (Gill and Ptashne, 1987). The activation domain of GCN4 
protein also bears an acidic character but the amino acid sequence in this region 
bears no homology to that of GAL4 protein (Ma and Ptashne, 1987b). Although 
acidic amino acids seem to impart transcription activation function to these 
proteins, there is poor correlation between the strength of activation and the 
number of acidic amino acid residues. Single amino acid changes reduce GCN4 
activation potential without much change in acidic character. Giniger and Ptashne 
(1987) constructed a gene encoding a 15 amino acid long polypeptide that is 
capable of forming an α-helix, one surface of which consists of negatively charged 
amino acids, while the other bears hydrophobic amino acids. When attached to a 
DNA binding domain, this peptide was found to activate transcription in yeast. 
Thus higher level of structural determinants such as an amphipathic helix with 
charged amino acids on one face, may be more important than the actual amino 
acid  sequence,  in  transcription  activation. 
The transcription activation domain of gene regulatory proteins need not always 
be acidic as shown in the case of glucocorticoid receptor, which consists of two well 
characterized enhancement domains, enh1 and enh2. The enh2 domain is very 
similar to the activation domain of GAL4 protein in containing several acidic 
amino acids and the distribution of negative charge is also similar between the two 
proteins. However, the enh1 domain is positively charged, containing 6 acidic and 
17 basic amino acid residues between amino acids 440 and 525 and it can function 
independantly of enh2 domain. It is suggested that these enhancement domains 
might display distinct activities in different cells or they might operate by entirely 
different  mechanisms  (Godowski  et  al.,  1988). 
 
Hybrid gene regulatory proteins 
 
One of the current approaches for the understanding of the mechanism of trans 
cription activation involves construction of hybrid regulatory proteins. It was 
shown that a chimeric protein consisting of the DNA binding domain of estrogen 
receptor and transcription activation domain of either GCN4 or GAL4 protein can 
activate a promoter containing estrogen responsive element (Webster et al., 1988). 
Similarly, a hybrid protein containing the DNA binding domain of E. coli lexA 
repressor and the trans-activation domain of GAL4 protein was able to activate 
transcription from a promoter containing lexA operator. In yet another study, the 
DNA binding domain of progesterone receptor was replaced by the corresponding 
region of glucocorticoid receptor and this hybrid protein specifically binds the 
glucocorticoid regulatory element and leads to progesterone dependant activation of 
heterologous genes (Green and Chambon, 1987). Recently, Hollis et al. (1988), 
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constructed a hybrid phage 434 repressor in which the DNA recognition helix was 
replaced by the corresponding region of phage P22 repressor. This chimeric protein 
binds specifically the P22 operator. Further, a dimer comprising of the 434 
repressor monomer and the chimeric 434-P22 repressor monomer specifically 
recognizes a chimeric operator that lacks the usual 2-fold symmetry, suggesting that 
combination of two DNA binding proteins may form a novel protein that 
recognizes  a  new  DNA  sequence. 
 
Protein-protein interactions 
 
The binding sites of gene regulatory proteins often lie several bp upstream of 
transcription start site. Thus arises the question as to how do these proteins, 
binding far upstream regions regulate transcription? A glimpse at the various 
eukaryotic genes reveals that transcription activation, often, is the result of the 
combined action of several regulatory proteins binding at different regions of the 
promoter. It is suggested that these proteins interact with one another leading to 
the formation of a DNA loop thereby bringing the upstream sites adjascent to the 
transcription start site. The evidences for such protein-protein interactions are, 
infact, overwhelming. For example, the carboxy terminal amino acids of TFIIIA are 
essential for the correct initiation of transcription and it is suggested that this 
region is involved in the binding of other components of the transcription 
machinery (Harrison, 1986). Similarly, the promoters of heat shock genes contain 
multiple copies of heat shock elements and it is proposed that the HSTF binds at 
these sites in a cooperative fashion and the binding of the first HSTF molecule 
causes a bend in DNA that facilitates the binding of the second HSTF molecule, 
whose binding results in additional conformation changes in the contacts of DNA 
to HSTF, triggering transcription (Shuey and Parker, 1986). In amphibian oocytes, 
heat shock element as well as the CCAAT box are essential for the efficient binding 
of HSTF to hsp70 promoter suggesting that the CCAAT box binding protein may 
interact with HSTF, thereby enhancing the affinity of the latter for the promoter 
(Beinz, 1986). The recognition sequences of SP1 factor are often found near the 
binding sites of other transcription factors such as AP1 or NF1 and it is believed 
that these factors may act in conjunction with one another and modulate transcrip 
tion (Kadonaga et al., 1987). Similar observations have been made in prokaryotes 
as well. For example, it was shown in the case of λ-repressor, which binds at the 
right operator (OR) of the λ-phage promoting the transcription of genes involved in 
lysogeny, that mutations in the amino terminal domain seriously disrupt the 
transcription activation function but the DNA binding function remains unaffected. 
It was suggested that the amino terminus represents the positive control domain 
and the repressor interacts with RNA polymerase through its amino terminal 
amino acids (Ptashne, 1986). It has recently been reported that the yeast GAL4 
protein can activate transcription synergistically in conjunction with several 
mammalian transcription factors such as activating transcription factor (ATF), 
upstream stimulating factor and glucocorticoid receptor (Kakidani and Ptashne, 
1988; Webster et al., 1988). It is believed that the interaction between any two 
transcription activators may be mediated by a common target protein such as 
TFIID, a TATA binding protein. Infact, it has been shown by Horikoshi et al. 
(1988), that ATF binds to multiple upstream elements of adenovirus E4 promoter 
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and alters the promoter interactions of TFIID and these interactions in turn 
facilitate promoter recognition by RNA polymerase II and the subsequent 
formation  of  pre  initiation  complex. 
It is to be mentioned here that motifs such as the leucine zipper play a very 
important role in facilitating protein-protein interactions among different 
transcription activators. For example, it has been shown recently that the leucine 
zipper stabilizes the interaction between fos and jun proteins and the fos–jun 
heteromer binds to DNA more tightly than either protein alone (Kouzarides and 
Ziff, 1988; Sassone-corsi et al., 1988). Thus, different transcription activators may 
interact with one another through motifs such as the leucine zipper and such 
interactions may lead to several combinations of dimers. A large number of such 
heteromers may indeed be involved in the regulation of transcription of eukaryotic 
gene families. 
 
Squelching 
 
Gill and Ptashne (1988) observed that the yeast GAL4 protein, when expressed at 
high levels, inhibits transcription of certain genes that lack GAL4 binding sites. This 
inhibitory effect, known as squelching, is independant of DNA binding domain, but 
involves the transcription activation domain. A GAL4 protein, lacking the DNA 
binding domain inhibits, whereas, a mutant lacking the activator domain does not 
inhibit. GAL4 derivatives possessing stronger activating domains inhibit more 
efficiently. It is suggested that squelching may be the result of the interaction 
between the activating domain of transcription factor and a target protein such as 
TFIID. When the transcription factor binds to DNA, its activating domain is 
brought into the immediate vicinity of the gene, where it interacts with a specific 
target protein leading to the formation of an active transcription complex. The target 
protein is present in limiting amounts and an activator protein may interact with 
the former even without binding to DNA and as a result, the transcription is 
blocked because of the nonavailability of the target protein. Thus, overproduction 
of a transcription activator would repress transcription from promoters lacking the 
activator binding sites and at very high concentrations, promoters bearing the 
binding sites would also be inhibited. These results suggest that the rate of 
transcription depends on the concentration of activators in the cell and the 
activator concentration should be regulated such that the activating domains are 
exposed only when required. The following examples indicate that such a regulation 
may indeed be operating in vivo. In yeast, the negative regulatory protein GAL80 
binds to the activating domain of GAL4 in the absence of galactose, thereby 
blocking transcription. In higher eukaryotes, steroid hormone receptors are 
complexed with hsp90 in the absence of steroid hormone. Several transcription 
factors are turned over rapidly, whereas in others, the activating domain is 
functional only when phosphorylated and regulation is effected at the level of 
phosphorylation (Ptashne, 1988). 
 
Cytochrome P-450 gene as a model system 
 
In this laboratory, detailed investigations have been carried out using rat liver 
cytochrome P-450 genes as a model system to study regulation of eukaryotic gene 
 
200 Rangarajan  and  Padmanaban 
 
transcription. Prototype chemicals such as phenobarbitone and 3-methylcholanthrene 
enhance the transcription of cytochrome P-450 b/e and c/d genes by 20–50-fold in 
the whole animal after a single injection (Ashwanikumar and Padmanaban, 1980; 
Ravishankar and Padmanaban, 1985). An interesting finding has been that heme, 
the prosthetic group of cytochrome P-450, is a positive modulator of the transcrip- 
tion of this gene (Ravishankar and Padmanaban, 1983; Sathyabhama et al., 1986; 
Bhat and Padmanaban, 1988). Studies also reveal that cycloheximide inhibits 
phenobarbitone or 3-methylcholanthrene mediated activation of the transcription of 
the respective P-450 genes implicating the possible involvement of a drug-induced 
transcription factor (Bhat et al., 1987). In support of this, nitrocellulose filter 
binding, gel retardation, foot print assays and south western blot analysis of the 
interaction between the upstream region of the P-450 b/e gene (Rangarajan et al., 
1987) and nuclear extracts, reveal drug- and heme-modulated binding of a 
transcription factor(s) to the upstream sites. A major protein involved has a 
molecular weight of 85 kDa. The binding of the transcription factor(s) to the 
upstream region correlates very well with the pattern of activation of transcription 
under different conditions of treatment (Rangarajan and Padmanaban, 1989). The 
system offers excellent scope to dissect the various processes associated with the 
phenomenon  of  transcription. 
 
Prospects 
 
Eukaryotic transcription, once considered an impenetrable black box, is now 
amenable for detailed analysis and significant information has already been 
accumulated. The generation of cell-free transcription systems responding to tissue 
and gene specific factors will help in understanding the process of selectivity in 
transcription activation. Negative interactions are as important as the positive ones, 
since the process of inactivation of genes and reasons for their silence need to be 
understood. The involvement of higher order structures of the genome in 
transcription regulation is still an open question. The main problem is to seggregate 
the cause from effect. Despite the complexity of chromatin structure, it is interesting 
to note that transcriptional activation state in a variety of systems is reflected in the 
functional consequence of the interaction between naked DNA and the 
transcription factors involved. Another interesting fact is the possible functional 
diversity of the transcription factors, which while manifesting specificity in one plan 
of architecture arising out of interaction with a set of proteins may show a different 
specificity in another combination or even assume the function of a replication 
factor. Finally, the regulatory potential of the different facets of transcription, 
namely, initiation, elongation and termination have to be understood and 
integrated. 
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